English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/207595
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

The specific seroreactivity to ∆Np73 isoforms shows higher diagnostic ability in colorectal cancer patients than the canonical p73 protein

AuthorsGarranzo Asensio, María; Guzmán-Aránguez, Ana I.; Povés, Carmen; Fernandez-Aceñero, M. Jesús; Montero-Calle, Ana; Cerón, María Ángeles; Fernández-Díez, Servando; Rodríguez, Nuria ; Gómez de Cedrón, Marta; Ramírez de Molina, Ana; Domínguez, Gemma; Barderas, Rodrigo
KeywordsDiagnostic markers
Tumour biomarkers
Issue Date19-Sep-2019
PublisherSpringer Nature
CitationScientific Reports 9: 13547 (2019)
AbstractThe p53-family is tightly regulated at transcriptional level. Due to alternative splicing, up to 40 different theoretical proteoforms have been described for p73 and at least 20 and 10 for p53 and p63, respectively. However, only the canonical proteins have been evaluated as autoantibody targets in cancer patients for diagnosis. In this study, we have cloned and expressed in vitro the most upregulated proteoforms of p73, ΔNp73α and ΔNp73β, for the analysis of their seroreactivity by a developed luminescence based immunoassay test using 145 individual plasma from colorectal cancer, premalignant individuals and healthy controls. ∆Np73α seroreactivity showed the highest diagnostic ability to discriminate between groups. The combination of ∆Np73α, ∆Np73β and p73 proteoforms seroreactivity were able to improve their individual diagnostic ability. Competitive inhibition experiments further demonstrated the presence of unique specific epitopes in ΔNp73 isoforms not present in p73, with several colorectal patients showing unique and specific seroreactivity to the ΔNp73 proteoforms. Overall, we have increased the complexity of the humoral immune response to the p53-family in cancer patients, showing that the proteoforms derived from the alternative splicing of p73 possess a higher diagnostic ability than the canonical protein, which might be extensive for p53 and p63 proteins.
Description© The Author(s) 2019.
Publisher version (URL)http://dx.doi.org/10.1038/s41598-019-49960-x
URIhttp://hdl.handle.net/10261/207595
DOI10.1038/s41598-019-49960-x
E-ISSN2045-2322
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
Specifc_Garranzo_Asensio_Art2019.pdf2,45 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.